What GTx Has achieved So Far…
GTx Inc. (NASDAQ:GTXI) is a Memphis, Tennessee-based, microcap biopharmaceutical company with a pipeline of small molecule, synthetic, hormone-like drugs to treat cancer, chemotherapy side effects, or provide cancer supportive care. Designation as a "small molecule" drug indicates a traditional big pharma discovery process and chemical structure, as opposed to the biologic drugs. The purpose of this article is to recap GTx's recent progress in furthering development of its lead drug candidate, enobosarm (GTX-024, formerly Ostarine). This report is longer than I prefer for my writing style, but a lot of good things have happened of late. As a "soft" positive, CEO Dr. Mitch Steiner had the honor of giving a one-hour seminar...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|